Financials • Specialty Insurers
$261.39 ▲ +10.60
(+4.23%)
MKT CAP: $11.58B • VOL: 720.0K
52W L $205 52W H $302
ROARABLE / RQD
B • 74/100
PIOTROSKI
8 / 9
ERIE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.07B | $3.80B | $3.27B |
| YoY Revenue Growth % | +7.2% | +16.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $717.2M | $676.5M | $520.3M |
| Operating Margin % | 17.6% | 17.8% | 15.9% |
| Net Income (GAAP) | $559.3M | $600.3M | $446.1M |
| EBITDA (Normalized) | $863.6M | $813.1M | $637.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $686.7M | $611.2M | $381.2M |
| Capital Expenditures (CapEx) | $183.0M | $170.8M | $147.1M |
| Free Cash Flow (FCF) | $503.6M | $440.5M | $234.1M |
| FCF Margin % | 12.4% | 11.6% | 7.2% |
| Return on Invested Capital (ROIC %) | 23.6% | 25.8% | 10.7% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $482.4M | $405.6M | $1.49B |
| Total Stockholders' Equity | $2.28B | $1.99B | $3.06B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ERIE.